Bio Pharma Dive
FEBRUARY 3, 2023
The biotech recently stopped a trial of its experimental conditioning regimen over safety concerns. Now it’s halting further development work as it undertakes a strategic review
Pharmaceutical Technology
FEBRUARY 3, 2023
Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 3, 2023
The company, which worked with GSK to develop a coronavirus shot, is ceasing operations after its corporate parent cut off further investment
Pharmaceutical Technology
FEBRUARY 3, 2023
Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. The company’s pharmaceutical sales recorded a 1% rise to $12.18bn compared to $12.03bn in the prior-year quarter.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Bio Pharma Dive
FEBRUARY 3, 2023
Among the drugs Roche recorded impairment charges on are four gene therapies acquired in the company's 2019 deal for Spark Therapeutics
Pharmaceutical Technology
FEBRUARY 3, 2023
The field of genomic medicine has reached a true turning point.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
FEBRUARY 3, 2023
The US Food and Drug Administration (FDA) has granted approval to Amgen and AstraZeneca ’s Tezspire (tezepelumab-ekko) for self-administration using a single-use, pre-filled pen for severe asthma patients aged 12 years and above.
Fierce Pharma
FEBRUARY 3, 2023
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries mbayer Fri, 02/03/2023 - 09:29
Pharmaceutical Technology
FEBRUARY 3, 2023
For EV drivers, range anxiety – the fear that an EV will run out of available battery charge before reaching its destination – is one of several pain points for the industry.
Fierce Pharma
FEBRUARY 3, 2023
Pressure's on, GSK. Merck's Keytruda drops endometrial cancer win in first-line treatment aliu Fri, 02/03/2023 - 09:43
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharmaceutical Technology
FEBRUARY 3, 2023
Biologic therapies are a mainstay in the management of various immunology indications, including rheumatoid arthritis (RA), psoriasis (PsO), axial spondyloarthritis (axSpA), atopic dermatitis (AD), Crohn’s disease (CD), and ulcerative colitis (UC), and serve as the key growth drivers in terms of commercial value in these indications.
Pharma Times
FEBRUARY 3, 2023
Partnership involves the study of real-time patient data and identification of adherence issues
Pharmaceutical Technology
FEBRUARY 3, 2023
Karuna Therapeutics has entered an exclusive licence agreement with Goldfinch Bio for investigational transient receptor potential canonical 4 and 5 (TRPC4/5) channel candidates. Karuna signed the deal with GFB, the assignee of the Goldfinch Bio assignment estate.
Pharma Times
FEBRUARY 3, 2023
MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn's Disease
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Pharmaceutical Technology
FEBRUARY 3, 2023
In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.
Fierce Pharma
FEBRUARY 3, 2023
With all eyes on new Alzheimer's med, Eisai lays off 91 staffers on its Fycompa team fkansteiner Fri, 02/03/2023 - 07:11
XTalks
FEBRUARY 3, 2023
The US Food and Drug Administration (FDA) has approved the first and only oral drug for the treatment of advanced or metastatic breast cancer in postmenopausal women or adult men with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) ESR1 mutations.
Fierce Pharma
FEBRUARY 3, 2023
After AbbVie, Teva walks away from influential trade group PhRMA fkansteiner Fri, 02/03/2023 - 15:53
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
XTalks
FEBRUARY 3, 2023
Loxo Oncology (Eli Lilly and Company) recently announced that their Bruton tyrosine kinase inhibitor (BTKi), Jaypirca (pirtobrutinib), was approved by the US Food and Drug Administration (FDA) to treat adults with relapsed or refractory mantle cell lymphoma (R/R MCL) under the Accelerated Approval pathway.
Fierce Pharma
FEBRUARY 3, 2023
Lilly-backed fund commits $24M to Recurv's push for clinical proof of concept of nano-emulsion taxane ntaylor Fri, 02/03/2023 - 07:16
Pharmaceutical Commerce
FEBRUARY 3, 2023
Jasmin Patel of a-Connect provides insight on how to navigate the ebbs and flows of employment.
Fierce Pharma
FEBRUARY 3, 2023
Mitsubishi Chemical bids adieu to Medicago—and the company's plant-based COVID shot Covifenz fkansteiner Fri, 02/03/2023 - 10:07
Roots Analysis
FEBRUARY 3, 2023
The American Society of Gene and Cell Therapy (ASGCT) defines cell therapy as a therapeutic modality that involves the administration of either normal or modified cells to patients for the treatment of various diseases. In this form of therapy, patients are injected with living and intact human cells that are deemed to be capable of providing therapeutic benefit.
Fierce Pharma
FEBRUARY 3, 2023
Gilead spotlights growth for HIV, cancer meds as COVID drug Veklury slides zbecker Fri, 02/03/2023 - 08:44
Drug Patent Watch
FEBRUARY 3, 2023
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in one NDA. It is available from two suppliers. There are twenty-seven patents… The post New patent for Salix Pharms drug XIFAXAN appeared first on DrugPatentWatch - Make Better Decisions.
Fierce Pharma
FEBRUARY 3, 2023
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023 zbecker Fri, 02/03/2023 - 22:02
Drug Patent Watch
FEBRUARY 3, 2023
Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two NDAs. There are eleven patents protecting this drug and six… The post New patent expiration for Endo Pharms drug OPANA ER appeared first on DrugPatentWatch - Make Better Decisions.
Fierce Pharma
FEBRUARY 3, 2023
Regeneron plans summer launch for longer-lasting version of Eylea as it tries to fend off rival Roche kdunleavy Fri, 02/03/2023 - 11:14
Drug Patent Watch
FEBRUARY 3, 2023
Annual Drug Patent Expirations for TUKYSA Tukysa is a drug marketed by Seagen and is included in one NDA. It is available from one supplier. There are five patents protecting… The post New patent for Seagen drug TUKYSA appeared first on DrugPatentWatch - Make Better Decisions. Patent Added
Drug Patent Watch
FEBRUARY 3, 2023
This chart shows the drugs with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical drugs have the most drug patents in Russian Federation? appeared first on DrugPatentWatch - Make Better Decisions. Infographic
Expert insights. Personalized for you.
314 
Let's personalize your content